Antimicrobial Susceptibility Testing Market Trends and Overview

The market size of Antimicrobial Susceptibility Testing was valued at USD 3.57 billion in 2022. It is projected to reach USD 5.66 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.9% during the forecast period from 2023 to 2030.

Antimicrobial Susceptibility Testing plays a crucial role in the field of healthcare, aiding in the selection of appropriate antibiotics for patients. With the increasing prevalence of antimicrobial resistance, the demand for accurate and reliable testing methods has surged. As a result, the market for Antimicrobial Susceptibility Testing is expected to witness substantial growth in the coming years.

The anticipated growth in this market can be attributed to several factors. Firstly, the rising incidence of infectious diseases, coupled with the emergence of drug-resistant pathogens, has created an urgent need for effective testing solutions. Additionally, the growing awareness among healthcare professionals regarding the importance of antimicrobial stewardship programs has further fueled the demand for advanced testing methods.

Furthermore, technological advancements in the field of diagnostics have revolutionized the Antimicrobial Susceptibility Testing market. The development of automated systems and rapid testing methods has significantly improved the efficiency and accuracy of testing procedures. These advancements have not only reduced the turnaround time for test results but have also enhanced the overall patient care experience.

Geographically, North America currently dominates the Antimicrobial Susceptibility Testing market, owing to the presence of well-established healthcare infrastructure and a high prevalence of infectious diseases. However, the Asia Pacific region is expected to witness the highest growth rate during the forecast period. Factors such as the increasing healthcare expenditure, rising awareness about antimicrobial resistance, and the growing demand for advanced diagnostic technologies in countries like China and India are driving the market growth in this region.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/1897

KEY MARKET SEGMENTATION:

By Product

• Manual Antimicrobial Susceptibility Testing Products
• Automated Laboratory Instruments
• Culture and Growth Media
• Consumables

By Type

• Antibacterial Susceptibility Testing
• Antifungal Susceptibility Testing
• Antiparasitic Susceptibility Testing
• Other Susceptibility Testing Types (slow-growing pathogens)

By Method

• Etest Method
• Disk Diffusion
• Automated Susceptibility Testing Instruments
• Agar Dilution
• Genotyping Methods

By End User

• Hospitals and Diagnostic Centers
• Pharmaceutical and Biotechnology Companies
• Research & Academic Institutes
• Clinical Research Organizations (CROs)

Major Players Listed in the Report are as Follows:

Bio-Rad, BD, Danaher, Thermo Fisher Scientific, Accelerate Diagnostics, Merck Group, Creative Diagnostics, Alifax, Roche Diagnostics Limited, Synbiosis and Other Players.

Other Report

Infection Surveillance Solutions Market

Healthcare IT Integration Market

Digital Pathology Market

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

[email protected],

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),

Website: https://www.snsinsider.com